Health TrialsbyHealthPanel

Aerobic and Resistance Training in Post-CABG Patients

ConditionsCoronary Artery DiseasePost Coronary Artery Bypass Grafting
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorUniversitas Padjadjaran

About this trial

This study investigates the effect of combined aerobic and resistance training using resistance bands on diaphragmatic excursion and pulmonary function (FVC, FEV₁, PEF) in post-CABG patients undergoing phase II cardiac rehabilitation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients post-CABG surgery maximum 12 weeks after the procedure

Age 40-65 years

Visual and hearing health

Ready to participate in research and sign informed consent.

Disqualifiers

Blood pressure greater than 160 mmHg for systolic and diastolic blood pressure greater than 100 mmHg

Patients with contraindications to aerobic and resistance training, such as fractures that limit movement.

Patients undergoing other therapies that may affect diaphragmatic muscle measurement results, such as electrical diaphragmatic stimulation.

Trial design

Design model

Single group

Treatments tested in this trial

  • Combination of aerobic training (treadmill walking) and resistance training

    Other intervention

    Combination of aerobic training (treadmill walking) and resistance training using resistance bands for deltoid, biceps, triceps, and quadriceps muscles. Conducted twice weekly for 6 weeks (12 sessions). Tools include treadmill and theraband loop bands.

Treatment groups

15 Participants
are divided into 1 treatment group
Group A: Aerobic and Resistance Training GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Diaphragm Excursion (cm)

The vertical movement of the diaphragm during the respiratory cycle shows the function and mobility of the diaphragm in the process of pulmonary ventilation. The data obtained is expressed in cm. Measured via ultrasound.

Time frame
Baseline to Week 6

Secondary outcomes

1

Forced Vital Capacity (FVC)

Lung function Forced Vital Capacity (FVC) is commonly assessed through spirometry and measured in liters (L) FVC: This measures the total volume of air that can be forcibly exhaled after a full inhalation. FVC values less than 80% of the predicted value are indicative of restrictive respiratory impairments, where the lungs cannot fully expand. FVC values equal to or greater than 80% are considered normal.

Time frame
Baseline to Week 6
2

Forced Expiratory Volume in one second (FEV1)

Lung function Forced Expiratory Volume in one second (FEV1) is commonly assessed through spirometry and measured in liters (L) FEV1: This represents the air volume a person can forcefully exhale in the first second of a breath.

Time frame
Baseline to Week 6
3

Peak Expiratory Flow (PEF)

Peak Expiratory Flow (PEF) is a spirometric parameter that measures the maximum airflow achieved at the beginning of a forced expiration, expressed in liters per second or minute. It reflects the function of the large airways and expiratory muscle strength. PEF interpretation is based on the percentage of predicted values according to age, sex, and height: ≥80% is considered normal, 60-79% indicates a mild reduction, 40-59% moderate reduction, and \<40% signifies a severe reduction.

Time frame
Baseline to Week 6

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universitas Padjadjaran

Lead sponsor

Dr. Hasan Sadikin General Hospital, Bandung, Indonesia

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: